Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structural motif supports binding affinity to certain receptors, making it valuable in the preparation of antidepressants and antipsychotic agents. The presence of both hydroxyl and morpholine groups allows for hydrogen bonding and improved solubility, enhancing drug efficacy and pharmacokinetic properties. Commonly employed in asymmetric synthesis routes where stereochemistry plays a critical role in biological activity.